Navamedic ASA (OL:NAVA) — Market Cap & Net Worth
Market Cap & Net Worth: Navamedic ASA (NAVA)
Navamedic ASA (OL:NAVA) has a market capitalization of $41.89 Million (Nkr398.09 Million) as of August 1, 2026. Listed on the OL stock exchange, this Norway-based company holds position #22509 globally and #206 in its home market, demonstrating a 2.47% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Navamedic ASA's stock price Nkr16.60 by its total outstanding shares 23981378 (23.98 Million). See NAVA capex reinvestment rate to understand how much of operating cash flow is reinvested back into capital assets.
Navamedic ASA Market Cap History: 2015 to 2026
Navamedic ASA's market capitalization history from 2015 to 2026. Data shows growth from $20.86 Million to $41.89 Million (8.13% CAGR).
Navamedic ASA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Navamedic ASA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.11x
Navamedic ASA's market cap is 0.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $25.42 Million | $274.30 Million | -$10.66 Million | 0.09x | N/A |
| 2017 | $20.37 Million | $257.92 Million | -$15.54 Million | 0.08x | N/A |
| 2018 | $23.87 Million | $184.02 Million | $7.28 Million | 0.13x | 3.28x |
| 2019 | $46.69 Million | $188.75 Million | -$16.30 Million | 0.25x | N/A |
| 2020 | $48.20 Million | $209.88 Million | -$16.46 Million | 0.23x | N/A |
| 2021 | $85.80 Million | $278.44 Million | $618.00K | 0.31x | 138.84x |
| 2022 | $88.07 Million | $382.13 Million | $29.43 Million | 0.23x | 2.99x |
| 2023 | $92.61 Million | $512.00 Million | $3.30 Million | 0.18x | 28.03x |
| 2024 | $64.85 Million | $531.44 Million | $1.29 Million | 0.12x | 50.28x |
| 2025 | $60.06 Million | $565.36 Million | -$23.54 Million | 0.11x | N/A |
Competitor Companies of NAVA by Market Capitalization
Companies near Navamedic ASA in the global market cap rankings as of August 1, 2026.
Key companies related to Navamedic ASA by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #272 globally with a market cap of $94.62 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #525 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #624 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1092 globally with a market cap of $24.01 Billion USD ( AU$33.94 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #272 | McKesson Corporation | NYSE:MCK | $94.62 Billion | $856.19 |
| #525 | Cencora Inc. | NYSE:COR | $50.53 Billion | $311.34 |
| #624 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $230.03 |
| #1092 | Sigma Healthcare Ltd | AU:SIG | $24.01 Billion | AU$2.94 |
Navamedic ASA Historical Marketcap From 2015 to 2026
Between 2015 and today, Navamedic ASA's market cap moved from $20.86 Million to $ 41.89 Million, with a yearly change of 8.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr41.89 Million | -30.25% |
| 2025 | Nkr60.06 Million | -7.39% |
| 2024 | Nkr64.85 Million | -29.97% |
| 2023 | Nkr92.61 Million | +5.16% |
| 2022 | Nkr88.07 Million | +2.65% |
| 2021 | Nkr85.80 Million | +78.01% |
| 2020 | Nkr48.20 Million | +3.24% |
| 2019 | Nkr46.69 Million | +95.60% |
| 2018 | Nkr23.87 Million | +17.14% |
| 2017 | Nkr20.37 Million | -19.85% |
| 2016 | Nkr25.42 Million | +21.86% |
| 2015 | Nkr20.86 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Navamedic ASA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $41.89 Million USD |
| MoneyControl | $41.89 Million USD |
| MarketWatch | $41.89 Million USD |
| marketcap.company | $41.89 Million USD |
| Reuters | $41.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. The company offers medical nutrition… Read more